SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : The thread of life -- Ignore unavailable to you. Want to Upgrade?

To: Mike McFarland who wrote (88)2/28/2001 12:23:01 PM
From: Mike McFarlandRespond to of 1336
 
I guess that was what they call fighting the tape:
siliconinvestor.com

Up around $19 at the time of the Famoxin spike,
Genset shares have since moved to around $6.

My cost is around $13.

Now I know the way folks suffered through the Gliatech debacle.
I avoided that mess with only small losses,
not so this time. Eventually everybody has one
of their favorites wiped off the board. Once
eight percent of my portfolio...now half that,
headed for even less, and I certainly wont buy
any more shares.

Whatever you are doing Mr. Pernet, stop it for godsake.



To: Mike McFarland who wrote (88)3/5/2001 11:01:52 PM
From: SpekulatiusRead Replies (1) | Respond to of 1336
 
Another frustrating day for Biotech investors.
Valuations for some stocks are actually less than in 1999, if the cash at hand is subtracted, INCY being a prime example. Have been picking up a little ABSC and CRXA for my IRA today. What else can one do?


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News